Pub Date : 2020-03-01DOI: 10.22141/2307-1257.9.2.2020.203411
F. Alberici, Elisa Delbarba, C. Manenti, L. Econimo, F. Valerio, A. Pola, C. Maffei, S. Possenti, P. Gaggia, E. Movilli, S. Bove, F. Malberti, M. Farina, M. Bracchi, E. Costantino, N. Bossini, M. Gaggiotti, F. Scolari
Пацієнт може знаходитись дома, повинен носити хірургічну маску постійно. Антивірусна терапія (тривалість: 5–20 днів визначається на основі клінічного прогресування): — лопінавір/ритонавір 200/50 мг 2 табл. двічі на добу, АБО — дарунавір 800 мг 1 табл. на добу + ритонавір 100 мг 1 табл. на день, АБО — дарунавір/кобіцистат 800/150 мг 1 табл. на добу. Терапія для взаємодій (http://www.covid19druginteractions.org/) Гідроксихлорохінін 200 мг після кожного сеансу діалізу (тричі на тиждень у пацієнтів на діалізі або двічі на тиждень). Емпірична антибіотикотерапія Тільки за наявності бактеріальної суперінфекції. Діалізна терапія У пацієнтів, які проходять гемодіафільтрацію, продовжують існуючий метод діалізу. У пацієнтів, які проходять діаліз, рекомендується використовувати фільтр Theranova з метою збільшення ефективності видалення молекул середнього розміру і, отже, медіаторів запалення. DOI: 10.22141/2307-1257.9.2.2020.203411 Federico Alberici, Elisa Delbarba, Chiara Manenti, Laura Econimo, Francesca Valerio, Alessandra Pola, Camilla Maffei, Stefano Possenti, Paola Gaggia, Ezio Movilli, Sergio Bove, Fabio Malberti, Marco Farina, Martina Bracchi, Ester Maria Costantino, Nicola Bossini, Mario Gaggiotti, Francesco Scolari on behalf of the “Brescia Renal Covid Task Force”
{"title":"Management of patients on dialysis and with kidney transplant during COVID-19 coronavirus infection","authors":"F. Alberici, Elisa Delbarba, C. Manenti, L. Econimo, F. Valerio, A. Pola, C. Maffei, S. Possenti, P. Gaggia, E. Movilli, S. Bove, F. Malberti, M. Farina, M. Bracchi, E. Costantino, N. Bossini, M. Gaggiotti, F. Scolari","doi":"10.22141/2307-1257.9.2.2020.203411","DOIUrl":"https://doi.org/10.22141/2307-1257.9.2.2020.203411","url":null,"abstract":"Пацієнт може знаходитись дома, повинен носити хірургічну маску постійно. Антивірусна терапія (тривалість: 5–20 днів визначається на основі клінічного прогресування): — лопінавір/ритонавір 200/50 мг 2 табл. двічі на добу, АБО — дарунавір 800 мг 1 табл. на добу + ритонавір 100 мг 1 табл. на день, АБО — дарунавір/кобіцистат 800/150 мг 1 табл. на добу. Терапія для взаємодій (http://www.covid19druginteractions.org/) Гідроксихлорохінін 200 мг після кожного сеансу діалізу (тричі на тиждень у пацієнтів на діалізі або двічі на тиждень). Емпірична антибіотикотерапія Тільки за наявності бактеріальної суперінфекції. Діалізна терапія У пацієнтів, які проходять гемодіафільтрацію, продовжують існуючий метод діалізу. У пацієнтів, які проходять діаліз, рекомендується використовувати фільтр Theranova з метою збільшення ефективності видалення молекул середнього розміру і, отже, медіаторів запалення. DOI: 10.22141/2307-1257.9.2.2020.203411 Federico Alberici, Elisa Delbarba, Chiara Manenti, Laura Econimo, Francesca Valerio, Alessandra Pola, Camilla Maffei, Stefano Possenti, Paola Gaggia, Ezio Movilli, Sergio Bove, Fabio Malberti, Marco Farina, Martina Bracchi, Ester Maria Costantino, Nicola Bossini, Mario Gaggiotti, Francesco Scolari on behalf of the “Brescia Renal Covid Task Force”","PeriodicalId":17874,"journal":{"name":"KIDNEYS","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87574279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.22141/2307-1257.9.1.2020.196919
No Authors
{"title":"American Diabetes Association Standards of Medical Care in Diabetes — 2020","authors":"No Authors","doi":"10.22141/2307-1257.9.1.2020.196919","DOIUrl":"https://doi.org/10.22141/2307-1257.9.1.2020.196919","url":null,"abstract":"","PeriodicalId":17874,"journal":{"name":"KIDNEYS","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85164250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.22141/2307-1257.9.1.2020.196909
No authors .
{"title":"To the World Kidney Day 2020. Kidney diseases — let’s be aware!","authors":"No authors .","doi":"10.22141/2307-1257.9.1.2020.196909","DOIUrl":"https://doi.org/10.22141/2307-1257.9.1.2020.196909","url":null,"abstract":"","PeriodicalId":17874,"journal":{"name":"KIDNEYS","volume":"45 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79711672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.22141/2307-1257.9.1.2020.196911
D. Ivanov, M. Ivanova
. The concepts of forced hydration and excessive forced hydration are discussed in the article. The authors emphasize that excessive forced hydration has a proven track record in improving the quality of life for dehydrated people. In case of normovolemia, there is no evidence of quality improvement and prolongation of life when excessive forced hydration is used. The issue of forced hydration in chronic kidney disease (CKD) is considered separately. Three randomized clinical trials were analyzed in which patients with CKD stage 1–2, 3 and 4–5 received forced hydration. The results of studies indicate the possible efficacy of forced hydration in stage 1–2 CKD in patients with normal or increased renal functional reserve. In stage 3 CKD, forced hydration showed no benefits, and in stage 4–5 CKD, it resulted in greater renal function loss. Summarizing these data, the authors concluded that it is probably appropriate for healthy people to consume the amount of fluid that provides physiological diuresis of 1.2–1.8 L and normal urine osmolarity. Forced hydration is often excessive, excessive forced hydration may not promote a healthy lifestyle. Forced hydration becomes excessive forced hydration as kidney function decreases. Possibly, the benefits of forced hydration are lost in CKD with progression of renal function loss. The effect of forced hydration for 12 months may be positive in stage 1 CKD and stage 2 CKD with normal renal functional reserve. Forced hydration is probably inexpedient in chronic stages 3–5.
{"title":"Hydration: the review of 3 trials","authors":"D. Ivanov, M. Ivanova","doi":"10.22141/2307-1257.9.1.2020.196911","DOIUrl":"https://doi.org/10.22141/2307-1257.9.1.2020.196911","url":null,"abstract":". The concepts of forced hydration and excessive forced hydration are discussed in the article. The authors emphasize that excessive forced hydration has a proven track record in improving the quality of life for dehydrated people. In case of normovolemia, there is no evidence of quality improvement and prolongation of life when excessive forced hydration is used. The issue of forced hydration in chronic kidney disease (CKD) is considered separately. Three randomized clinical trials were analyzed in which patients with CKD stage 1–2, 3 and 4–5 received forced hydration. The results of studies indicate the possible efficacy of forced hydration in stage 1–2 CKD in patients with normal or increased renal functional reserve. In stage 3 CKD, forced hydration showed no benefits, and in stage 4–5 CKD, it resulted in greater renal function loss. Summarizing these data, the authors concluded that it is probably appropriate for healthy people to consume the amount of fluid that provides physiological diuresis of 1.2–1.8 L and normal urine osmolarity. Forced hydration is often excessive, excessive forced hydration may not promote a healthy lifestyle. Forced hydration becomes excessive forced hydration as kidney function decreases. Possibly, the benefits of forced hydration are lost in CKD with progression of renal function loss. The effect of forced hydration for 12 months may be positive in stage 1 CKD and stage 2 CKD with normal renal functional reserve. Forced hydration is probably inexpedient in chronic stages 3–5.","PeriodicalId":17874,"journal":{"name":"KIDNEYS","volume":"284 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86398022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-11-01DOI: 10.22141/2307-1257.8.4.2019.185122
K. Wiles, L. Chappell, K. Clark, L. Elman, M. Hall, L. Lightstone, Germin Mohamed, Durba Mukherjee, C. Nelson-Piercy, P. Webster, Rebecca Whybrow, K. Bramham, D. D. I. transl., I. K. transl.
Короткий зміст настанов клінічної практики Структура медичної допомоги Настанова 1.1 Ми рекомендуємо створювати мультидисциплінарні команди (включаючи лікаря-акушера, консультанта лікарянефролога/лікаря-експерта, а також акушерку чи акушерську групу) для надання консультацій і допомоги жінкам із ХХН, які вагітні або планують вагітність. Усі медичні працівники, які доглядають за жінками з ХХН, повинні мати доступ до цієї мультидисциплінарної команди (1D).
{"title":"The Renal Association Clinical Practice Guideline on Pregnancy аnd Renal Disease","authors":"K. Wiles, L. Chappell, K. Clark, L. Elman, M. Hall, L. Lightstone, Germin Mohamed, Durba Mukherjee, C. Nelson-Piercy, P. Webster, Rebecca Whybrow, K. Bramham, D. D. I. transl., I. K. transl.","doi":"10.22141/2307-1257.8.4.2019.185122","DOIUrl":"https://doi.org/10.22141/2307-1257.8.4.2019.185122","url":null,"abstract":"Короткий зміст настанов клінічної практики Структура медичної допомоги Настанова 1.1 Ми рекомендуємо створювати мультидисциплінарні команди (включаючи лікаря-акушера, консультанта лікарянефролога/лікаря-експерта, а також акушерку чи акушерську групу) для надання консультацій і допомоги жінкам із ХХН, які вагітні або планують вагітність. Усі медичні працівники, які доглядають за жінками з ХХН, повинні мати доступ до цієї мультидисциплінарної команди (1D).","PeriodicalId":17874,"journal":{"name":"KIDNEYS","volume":"37 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77249433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-11-01DOI: 10.22141/2307-1257.8.4.2019.185124
I. Golovach, Y. Yehudina
{"title":"Psoriatic nephropathy: the nature, manifestation spectrum and evidence of kidney damage in psoriasis","authors":"I. Golovach, Y. Yehudina","doi":"10.22141/2307-1257.8.4.2019.185124","DOIUrl":"https://doi.org/10.22141/2307-1257.8.4.2019.185124","url":null,"abstract":"","PeriodicalId":17874,"journal":{"name":"KIDNEYS","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91325777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-11-01DOI: 10.22141/2307-1257.8.4.2019.185123
O. Taran
{"title":"Treatment of arterial hypertension in pregnant women","authors":"O. Taran","doi":"10.22141/2307-1257.8.4.2019.185123","DOIUrl":"https://doi.org/10.22141/2307-1257.8.4.2019.185123","url":null,"abstract":"","PeriodicalId":17874,"journal":{"name":"KIDNEYS","volume":"62 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76191179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-11-01DOI: 10.22141/2307-1257.8.4.2019.185121
S. Kanagasundaram, C. Ashley, S. Bhojani, A. Caldwell, T. Ellam, A. Kaur, D. Milford, C. Mulgrew, M. Ostermann, D. D. Ivanov transl., I. Kuchma transl.
{"title":"The Renal Association Clinical Practice Guideline Acute Kidney Injury (AKI), August 2019","authors":"S. Kanagasundaram, C. Ashley, S. Bhojani, A. Caldwell, T. Ellam, A. Kaur, D. Milford, C. Mulgrew, M. Ostermann, D. D. Ivanov transl., I. Kuchma transl.","doi":"10.22141/2307-1257.8.4.2019.185121","DOIUrl":"https://doi.org/10.22141/2307-1257.8.4.2019.185121","url":null,"abstract":"","PeriodicalId":17874,"journal":{"name":"KIDNEYS","volume":"38 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73194270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-11-01DOI: 10.22141/2307-1257.8.4.2019.185118
S. O. Soshinskyi, D. Ivanov
{"title":"About opportunities for continuous professional development of nephrologists","authors":"S. O. Soshinskyi, D. Ivanov","doi":"10.22141/2307-1257.8.4.2019.185118","DOIUrl":"https://doi.org/10.22141/2307-1257.8.4.2019.185118","url":null,"abstract":"","PeriodicalId":17874,"journal":{"name":"KIDNEYS","volume":"76 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74368865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-11-01DOI: 10.22141/2307-1257.8.4.2019.185117
D. Ivanov
{"title":"Phytotherapy and treatment of cystitis: current trends","authors":"D. Ivanov","doi":"10.22141/2307-1257.8.4.2019.185117","DOIUrl":"https://doi.org/10.22141/2307-1257.8.4.2019.185117","url":null,"abstract":"","PeriodicalId":17874,"journal":{"name":"KIDNEYS","volume":"36 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81905293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：